You are here

Article info

Article menu

Download PDFPDF

Review
Biomarkers for response to TIL therapy: a comprehensive review

Authors

  • Víctor Albarrán Fernández National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, DenmarkRamón y Cajal University Hospital, Department of Medical Oncology, Madrid, Spain PubMed articlesGoogle scholar articles
  • Pablo Ballestín Martínez National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, DenmarkClínico San Carlos University Hospital, Department of Medical Oncology, Madrid, Spain PubMed articlesGoogle scholar articles
  • Joachim Stoltenborg Granhøj National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark PubMed articlesGoogle scholar articles
  • Troels Holz Borch National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark PubMed articlesGoogle scholar articles
  • Marco Donia National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark PubMed articlesGoogle scholar articles
  • Inge Marie Svane National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark PubMed articlesGoogle scholar articles

Citation

Albarrán Fernández V, Ballestín Martínez P, Stoltenborg Granhøj J, et al
Biomarkers for response to TIL therapy: a comprehensive review
Journal for ImmunoTherapy of Cancer 2024;12:e008640. doi: 10.1136/jitc-2023-008640
Online issue publication 
March 13, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.